药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ceforanide
Oxatomide
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Oxatomide.
Ceforanide
Abexinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Abexinostat.
Ceforanide
Mizolastine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Mizolastine.
Ceforanide
Ricolinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Ricolinostat.
Ceforanide
CUDC-101
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with CUDC-101.
Ceforanide
Gilteritinib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Gilteritinib.
Ceforanide
Entinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Entinostat.
Ceforanide
Mocetinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Mocetinostat.
Ceforanide
Amifampridine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Amifampridine.
Ceforanide
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Dexchlorpheniramine maleate.
Ceforanide
Lenvatinib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Lenvatinib.
Ceforanide
Butriptyline
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Butriptyline.
Ceforanide
Bedaquiline
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Bedaquiline.
Ceforanide
Crizotinib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Crizotinib.
Ceforanide
Antazoline
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Antazoline.
Ceforanide
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Nemonoxacin.
Ceforanide
Pazopanib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Pazopanib.
Ceforanide
Telavancin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Telavancin.
Ceforanide
Tucidinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Tucidinostat.
Ceforanide
Garenoxacin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Garenoxacin.